インド遺伝子合成市場-2030年までの産業動向予測India Gene Synthesis Market - Industry Trends Forecast to 2030 インドの遺伝子合成市場は、2022年の7,477万米ドルから2030年には4億5,981万米ドルに達し、2023年から2030年の予測期間中に年平均成長率25.5%で成長すると予測されている。 市場セグメンテーション インド遺... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーインドの遺伝子合成市場は、2022年の7,477万米ドルから2030年には4億5,981万米ドルに達し、2023年から2030年の予測期間中に年平均成長率25.5%で成長すると予測されている。市場セグメンテーション インド遺伝子合成市場:コンポーネント別(合成装置、消耗品、ソフトウェア&サービス)、遺伝子タイプ別(標準遺伝子、発現遺伝子、複合遺伝子、その他)、遺伝子合成タイプ別(遺伝子ライブラリー合成、カスタム遺伝子合成)、用途別(合成生物学、遺伝子工学、ワクチン設計、抗体治療、その他)、手法別(固相合成、チップベースDNA合成、PCRベース酵素合成)。エンドユーザー(学術・研究機関、診断研究所、バイオテクノロジー・製薬会社、CRO(医薬品開発業務受託機関)、農業、食品、その他)、流通チャネル(直接入札、オンライン流通、第三者流通)、国(インド)-産業動向と2030年までの予測 インド遺伝子合成市場ダイナミクスの概要 促進要因 - 慢性感染症の増加 抑制要因 - 訓練を受けた専門家の不足 機会 - 医療費の増加 市場プレイヤー インド遺伝子合成市場に参入している主な市場プレイヤーは以下の通り: - サーモフィッシャーサイエンティフィック社 - ボスター・バイオロジカル・テクノロジー - ツイストバイオサイエンス - オリジーン・テクノロジー社 - ユーロフィンズ・サイエンティフィック - ジェンスクリプト - メルクKGaA - カネカ・ユーロジェンテック S.A - シンバイオ・テクノロジー - GCCバイオテック(インド)社 目次TABLE OF CONTENTS1 INTRODUCTION 11 1.1 OBJECTIVES OF THE STUDY 11 1.2 MARKET DEFINITION 11 1.3 OVERVIEW OF INDIA GENE SYNTHESIS MARKET 11 1.4 CURRENCY AND PRICING 13 1.5 LIMITATION 13 1.6 MARKETS COVERED 13 2 MARKET SEGMENTATION 15 2.1 MARKETS COVERED 15 2.2 GEOGRAPHIC SCOPE 16 2.3 YEARS CONSIDERED FOR THE STUDY 16 2.4 CURRENCY AND PRICING 16 2.5 RESEARCH METHODOLOGY 17 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 20 2.7 MULTIVARIATE MODELLING 21 2.8 COMPONENT SEGMENT LIFELINE CURVE 21 2.9 DBMR MARKET POSITION GRID 22 2.10 MARKET APPLICATION COVERAGE GRID 24 2.11 THE CATEGORY VS TIME GRID 25 2.12 SECONDARY SOURCES 26 2.13 ASSUMPTIONS 26 3 EXECUTIVE SUMMARY 27 4 PREMIUM INSIGHTS 30 4.1 PESTEL 31 4.2 PORTER'S FIVE FORCES MODEL 32 4.3 MARKET POTENTIAL 33 4.4 PRICING ANALYSIS 35 5 INDIA GENE SYNTHESIS MARKET: REGULATIONS 37 6 MARKET OVERVIEW 38 6.1 DRIVERS 40 6.1.1 INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES 40 6.1.2 RISING ADOPTION OF GENE THERAPY 40 6.1.3 EXPANSION OF SYNTHETIC BIOLOGY 41 6.1.4 RISING INTEREST IN GENE SYNTHESIS IN THE FIELD OF MOLECULAR BIOLOGY 42 6.2 RESTRAINTS 42 6.2.1 LACK OF TRAINED PROFESSIONALS 42 6.2.2 ETHICAL ISSUES 43 6.3 OPPORTUNITIES 43 6.3.1 RISE IN HEALTHCARE EXPENDITURE 43 6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 44 6.3.3 RISING DEMAND FOR CUSTOMIZED/PERSONALIZED MEDICATIONS 44 6.4 CHALLENGES 45 6.4.1 TECHNICAL LIMITATIONS ACROSS THE PRODUCTION PROCESS 45 6.4.2 REGULATORY FRAMEWORK 45 7 INDIA GENE SYNTHESIS MARKET, BY COMPONENT 46 7.1 OVERVIEW 47 7.2 SOFTWARE & SERVICES 50 7.3 CONSUMABLES 50 7.3.1 REAGENTS 50 7.3.2 ASSAYS 50 7.3.3 PROBES & DYES 50 7.3.4 OTHERS 50 7.4 SYNTHESIZER 51 7.4.1 COLUMN-BASED SYNTHESIZERS 51 7.4.2 MICROARRAY-BASED SYNTHESIZERS 51 8 INDIA GENE SYNTHESIS MARKET, BY GENE TYPE 52 8.1 OVERVIEW 53 8.2 STANDARD GENE 56 8.3 COMPLEX GENE 56 8.4 EXPRESS GENE 56 8.5 OTHERS 56 9 INDIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE 57 9.1 OVERVIEW 58 9.2 CUSTOM GENE SYNTHESIS 61 9.2.1 STANDARD GENE 61 9.2.2 COMPLEX GENE 61 9.2.3 EXPRESS GENE 61 9.2.4 OTHERS 61 9.3 GENE LIBRARY SYNTHESIS 62 9.3.1 STANDARD GENE 62 9.3.2 COMPLEX GENE 62 9.3.3 EXPRESS GENE 62 9.3.4 OTHERS 62 10 INDIA GENE SYNTHESIS MARKET, BY APPLICATION 63 10.1 OVERVIEW 64 10.2 SYNTHETIC BIOLOGY 67 10.2.1 CUSTOM GENE SYNTHESIS 67 10.2.2 GENE LIBRARY SYNTHESIS 67 10.3 GENETIC ENGINEERING 67 10.3.1 CUSTOM GENE SYNTHESIS 68 10.3.2 GENE LIBRARY SYNTHESIS 68 10.4 THERAPEUTIC ANTIBODIES 68 10.4.1 CUSTOM GENE SYNTHESIS 68 10.4.2 GENE LIBRARY SYNTHESIS 68 10.5 VACCINE DESIGN 69 10.5.1 CUSTOM GENE SYNTHESIS 69 10.5.2 GENE LIBRARY SYNTHESIS 69 10.6 OTHERS 69 11 INDIA GENE SYNTHESIS MARKET, BY METHOD 70 11.1 OVERVIEW 71 11.2 PCR-BASED ENZYME SYNTHESIS 74 11.3 CHIP-BASED DNA SYNTHESIS 74 11.4 SOLID BASED SYNTHESIS 74 12 INDIA GENE SYNTHESIS MARKET, BY END USER 75 12.1 OVERVIEW 76 12.2 ACADEMIC & RESEARCH INSTITUTE 79 12.3 BIOTECH & PHARMACEUTICAL COMPANIES 79 12.4 CONTRACT RESEARCH ORGANIZATIONS (CROS) 79 12.5 DIAGNOSTIC LABORATORIES 79 12.6 AGRICULTURE 79 12.7 FOOD 79 12.8 OTHERS 79 13 INDIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL 80 13.1 OVERVIEW 81 13.2 DIRECT TENDER 84 13.3 ONLINE DISTRIBUTION 84 13.4 THIRD PARTY DISTRIBUTORS 84 14 INDIA GENE SYNTHESIS MARKET: COMPANY LANDSCAPE 85 14.1 COMPANY SHARE ANALYSIS: INDIA 85 15 SWOT ANALYSIS 86 16 COMPANY PROFILE 87 16.1 THERMO FISHER SCIENTIFIC INC. 87 16.1.1 COMPANY SNAPSHOT 87 16.1.2 REVENUE ANALYSIS 87 16.1.3 PRODUCT PORTFOLIO 88 16.1.4 RECENT DEVELOPMENT 88 16.2 EUROFINS SCIENTIFIC 89 16.2.1 COMPANY SNAPSHOT 89 16.2.2 REVENUE ANALYSIS 89 16.2.3 SERVICE PORTFOLIO 90 16.2.4 RECENT DEVELOPMENT 90 16.3 MERCK KGAA 91 16.3.1 COMPANY SNAPSHOT 91 16.3.2 REVENUE ANALYSIS 91 16.3.3 PRODUCT PORTFOLIO 92 16.3.4 RECENT DEVELOPMENT 92 16.4 KANEKA EUROGENTEC S.A. 93 16.4.1 COMPANY SNAPSHOT 93 16.4.2 REVENUE ANALYSIS 93 16.4.3 PRODUCT PORTFOLIO 94 16.4.4 RECENT DEVELOPMENTS 94 16.5 BOSTER BIOLOGICAL TECHNOLOGY 95 16.5.1 COMPANY SNAPSHOT 95 16.5.2 SERVICE PORTFOLIO 95 16.5.3 RECENT DEVELOPMENT 95 16.6 GCC BIOTECH (INDIA) PVT. LTD. 96 16.6.1 COMPANY SNAPSHOT 96 16.6.2 PRODUCT PORTFOLIO 96 16.6.3 RECENT DEVELOPMENT 96 16.7 GENSCRIPT 97 16.7.1 COMPANY SNAPSHOT 97 16.7.2 REVENUE ANALYSIS 97 16.7.3 PRODUCT PORTFOLIO 98 16.7.4 RECENT DEVELOPMENTS 98 16.8 ORIGENE TECHNOLOGIES, INC 99 16.8.1 COMPANY SNAPSHOT 99 16.8.2 PRODUCT PORTFOLIO 99 16.8.3 RECENT DEVELOPMENTS 99 16.9 SYNBIO TECHNOLOGIES 100 16.9.1 COMPANY SNAPSHOT 100 16.9.2 PRODUCT PORTFOLIO 100 16.9.3 RECENT DEVELOPMENTS 100 16.10 TWIST BIOSCIENCE 101 16.10.1 COMPANY SNAPSHOT 101 16.10.2 REVENUE ANALYSIS 101 16.10.3 PRODUCT PORTFOLIO 102 16.10.4 RECENT DEVELOPMENTS 102 17 QUESTIONNAIRE 103 18 RELATED REPORTS 107
SummaryThe India Gene synthesis market is expected to reach USD 459.81 million by 2030 from USD 74.77 million in 2022, growing at a CAGR of 25.5% during the forecast period of 2023 to 2030. Table of ContentsTABLE OF CONTENTS1 INTRODUCTION 11 1.1 OBJECTIVES OF THE STUDY 11 1.2 MARKET DEFINITION 11 1.3 OVERVIEW OF INDIA GENE SYNTHESIS MARKET 11 1.4 CURRENCY AND PRICING 13 1.5 LIMITATION 13 1.6 MARKETS COVERED 13 2 MARKET SEGMENTATION 15 2.1 MARKETS COVERED 15 2.2 GEOGRAPHIC SCOPE 16 2.3 YEARS CONSIDERED FOR THE STUDY 16 2.4 CURRENCY AND PRICING 16 2.5 RESEARCH METHODOLOGY 17 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 20 2.7 MULTIVARIATE MODELLING 21 2.8 COMPONENT SEGMENT LIFELINE CURVE 21 2.9 DBMR MARKET POSITION GRID 22 2.10 MARKET APPLICATION COVERAGE GRID 24 2.11 THE CATEGORY VS TIME GRID 25 2.12 SECONDARY SOURCES 26 2.13 ASSUMPTIONS 26 3 EXECUTIVE SUMMARY 27 4 PREMIUM INSIGHTS 30 4.1 PESTEL 31 4.2 PORTER'S FIVE FORCES MODEL 32 4.3 MARKET POTENTIAL 33 4.4 PRICING ANALYSIS 35 5 INDIA GENE SYNTHESIS MARKET: REGULATIONS 37 6 MARKET OVERVIEW 38 6.1 DRIVERS 40 6.1.1 INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES 40 6.1.2 RISING ADOPTION OF GENE THERAPY 40 6.1.3 EXPANSION OF SYNTHETIC BIOLOGY 41 6.1.4 RISING INTEREST IN GENE SYNTHESIS IN THE FIELD OF MOLECULAR BIOLOGY 42 6.2 RESTRAINTS 42 6.2.1 LACK OF TRAINED PROFESSIONALS 42 6.2.2 ETHICAL ISSUES 43 6.3 OPPORTUNITIES 43 6.3.1 RISE IN HEALTHCARE EXPENDITURE 43 6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 44 6.3.3 RISING DEMAND FOR CUSTOMIZED/PERSONALIZED MEDICATIONS 44 6.4 CHALLENGES 45 6.4.1 TECHNICAL LIMITATIONS ACROSS THE PRODUCTION PROCESS 45 6.4.2 REGULATORY FRAMEWORK 45 7 INDIA GENE SYNTHESIS MARKET, BY COMPONENT 46 7.1 OVERVIEW 47 7.2 SOFTWARE & SERVICES 50 7.3 CONSUMABLES 50 7.3.1 REAGENTS 50 7.3.2 ASSAYS 50 7.3.3 PROBES & DYES 50 7.3.4 OTHERS 50 7.4 SYNTHESIZER 51 7.4.1 COLUMN-BASED SYNTHESIZERS 51 7.4.2 MICROARRAY-BASED SYNTHESIZERS 51 8 INDIA GENE SYNTHESIS MARKET, BY GENE TYPE 52 8.1 OVERVIEW 53 8.2 STANDARD GENE 56 8.3 COMPLEX GENE 56 8.4 EXPRESS GENE 56 8.5 OTHERS 56 9 INDIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE 57 9.1 OVERVIEW 58 9.2 CUSTOM GENE SYNTHESIS 61 9.2.1 STANDARD GENE 61 9.2.2 COMPLEX GENE 61 9.2.3 EXPRESS GENE 61 9.2.4 OTHERS 61 9.3 GENE LIBRARY SYNTHESIS 62 9.3.1 STANDARD GENE 62 9.3.2 COMPLEX GENE 62 9.3.3 EXPRESS GENE 62 9.3.4 OTHERS 62 10 INDIA GENE SYNTHESIS MARKET, BY APPLICATION 63 10.1 OVERVIEW 64 10.2 SYNTHETIC BIOLOGY 67 10.2.1 CUSTOM GENE SYNTHESIS 67 10.2.2 GENE LIBRARY SYNTHESIS 67 10.3 GENETIC ENGINEERING 67 10.3.1 CUSTOM GENE SYNTHESIS 68 10.3.2 GENE LIBRARY SYNTHESIS 68 10.4 THERAPEUTIC ANTIBODIES 68 10.4.1 CUSTOM GENE SYNTHESIS 68 10.4.2 GENE LIBRARY SYNTHESIS 68 10.5 VACCINE DESIGN 69 10.5.1 CUSTOM GENE SYNTHESIS 69 10.5.2 GENE LIBRARY SYNTHESIS 69 10.6 OTHERS 69 11 INDIA GENE SYNTHESIS MARKET, BY METHOD 70 11.1 OVERVIEW 71 11.2 PCR-BASED ENZYME SYNTHESIS 74 11.3 CHIP-BASED DNA SYNTHESIS 74 11.4 SOLID BASED SYNTHESIS 74 12 INDIA GENE SYNTHESIS MARKET, BY END USER 75 12.1 OVERVIEW 76 12.2 ACADEMIC & RESEARCH INSTITUTE 79 12.3 BIOTECH & PHARMACEUTICAL COMPANIES 79 12.4 CONTRACT RESEARCH ORGANIZATIONS (CROS) 79 12.5 DIAGNOSTIC LABORATORIES 79 12.6 AGRICULTURE 79 12.7 FOOD 79 12.8 OTHERS 79 13 INDIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL 80 13.1 OVERVIEW 81 13.2 DIRECT TENDER 84 13.3 ONLINE DISTRIBUTION 84 13.4 THIRD PARTY DISTRIBUTORS 84 14 INDIA GENE SYNTHESIS MARKET: COMPANY LANDSCAPE 85 14.1 COMPANY SHARE ANALYSIS: INDIA 85 15 SWOT ANALYSIS 86 16 COMPANY PROFILE 87 16.1 THERMO FISHER SCIENTIFIC INC. 87 16.1.1 COMPANY SNAPSHOT 87 16.1.2 REVENUE ANALYSIS 87 16.1.3 PRODUCT PORTFOLIO 88 16.1.4 RECENT DEVELOPMENT 88 16.2 EUROFINS SCIENTIFIC 89 16.2.1 COMPANY SNAPSHOT 89 16.2.2 REVENUE ANALYSIS 89 16.2.3 SERVICE PORTFOLIO 90 16.2.4 RECENT DEVELOPMENT 90 16.3 MERCK KGAA 91 16.3.1 COMPANY SNAPSHOT 91 16.3.2 REVENUE ANALYSIS 91 16.3.3 PRODUCT PORTFOLIO 92 16.3.4 RECENT DEVELOPMENT 92 16.4 KANEKA EUROGENTEC S.A. 93 16.4.1 COMPANY SNAPSHOT 93 16.4.2 REVENUE ANALYSIS 93 16.4.3 PRODUCT PORTFOLIO 94 16.4.4 RECENT DEVELOPMENTS 94 16.5 BOSTER BIOLOGICAL TECHNOLOGY 95 16.5.1 COMPANY SNAPSHOT 95 16.5.2 SERVICE PORTFOLIO 95 16.5.3 RECENT DEVELOPMENT 95 16.6 GCC BIOTECH (INDIA) PVT. LTD. 96 16.6.1 COMPANY SNAPSHOT 96 16.6.2 PRODUCT PORTFOLIO 96 16.6.3 RECENT DEVELOPMENT 96 16.7 GENSCRIPT 97 16.7.1 COMPANY SNAPSHOT 97 16.7.2 REVENUE ANALYSIS 97 16.7.3 PRODUCT PORTFOLIO 98 16.7.4 RECENT DEVELOPMENTS 98 16.8 ORIGENE TECHNOLOGIES, INC 99 16.8.1 COMPANY SNAPSHOT 99 16.8.2 PRODUCT PORTFOLIO 99 16.8.3 RECENT DEVELOPMENTS 99 16.9 SYNBIO TECHNOLOGIES 100 16.9.1 COMPANY SNAPSHOT 100 16.9.2 PRODUCT PORTFOLIO 100 16.9.3 RECENT DEVELOPMENTS 100 16.10 TWIST BIOSCIENCE 101 16.10.1 COMPANY SNAPSHOT 101 16.10.2 REVENUE ANALYSIS 101 16.10.3 PRODUCT PORTFOLIO 102 16.10.4 RECENT DEVELOPMENTS 102 17 QUESTIONNAIRE 103 18 RELATED REPORTS 107
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポートData Bridge Market Research社の医薬分野での最新刊レポート
本レポートと同じKEY WORD(industry)の最新刊レポートよくあるご質問Data Bridge Market Research社はどのような調査会社ですか?データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |